Richard Gilson

16.9k total citations · 1 hit paper
196 papers, 7.3k citations indexed

About

Richard Gilson is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Richard Gilson has authored 196 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Epidemiology, 96 papers in Infectious Diseases and 54 papers in Virology. Recurrent topics in Richard Gilson's work include HIV/AIDS Research and Interventions (76 papers), HIV Research and Treatment (53 papers) and Hepatitis B Virus Studies (46 papers). Richard Gilson is often cited by papers focused on HIV/AIDS Research and Interventions (76 papers), HIV Research and Treatment (53 papers) and Hepatitis B Virus Studies (46 papers). Richard Gilson collaborates with scholars based in United Kingdom, United States and Australia. Richard Gilson's co-authors include Mala K. Maini, Andrew Phillips, Richard S. Tedder, Caroline Sabin, Alison Rodger, Margaret Johnson, Dimitra Peppa, Antonio Bertoletti, Martin Fisher and Ian Weller and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Richard Gilson

194 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection

2000 658 citations Richard Gilson et al. profile →

Peers

Countries citing papers authored by Richard Gilson

Since Specialization

Citations

This map shows the geographic impact of Richard Gilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Gilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Gilson more than expected).

Fields of papers citing papers by Richard Gilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Gilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Gilson. The network helps show where Richard Gilson may publish in the future.

Co-authorship network of co-authors of Richard Gilson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Gilson. A scholar is included among the top collaborators of Richard Gilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Gilson. Richard Gilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective study 2023 ·Sexually Transmitted Infections ·Robert Hammond, Valentina Cambiano, Fiona Lampe, David Asboe, Amanda Clarke, Richard Gilson, Graham Hart, Ada Miltz, Nneka Nwokolo, Margaret Johnson, Andrew Phillips, Andrew Speakman, Gary Whitlock, Alison Rodger, Janey Sewell	5
2	Obesity in women living with HIV aged 45–60 in England: An analysis of the PRIME study 2022 ·HIV Medicine ·(unknown), Hajra Okhai, Caroline Sabin, Lorraine Sherr, (unknown), Rageshri Dhairyawan, Richard Gilson, Fiona Burns, (unknown), Shema Tariq	8
3	Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCT 2021 ·Health Technology Assessment ·Sharon Cameron, Anna Glasier, Lisa McDaid, Andrew Radley, Susan Patterson, Paula Baraitser, Judith Stephenson, Richard Gilson, Claire Battison, (unknown), Thenmalar Vadiveloo, Anne Johnstone, Alessandra Morelli, Beatriz Goulão, Mark Forrest, Alison McDonald, John Norrie	3
4	Trends in HIV incidence between 2013–2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study 2021 ·PLoS Medicine ·(unknown), Valentina Cambiano, Janey Sewell, Alison Rodger, Nneka Nwokolo, David Asboe, Richard Gilson, Amanda Clarke, Ada Miltz, Simon Collins, Valérie Delpech, Sara Croxford, Andrew Phillips, Fiona Lampe, (unknown)	16
5	Ethnic inequalities in mental health and socioeconomic status among older women living with HIV: results from the PRIME Study 2021 ·Sexually Transmitted Infections ·(unknown), Shema Tariq, (unknown), Fiona Burns, Richard Gilson, Caroline Sabin, Lorraine Sherr, (unknown), Rageshri Dhairyawan	13
6	Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT 2020 ·Health Technology Assessment ·Richard Gilson, Diarmuid Nugent, Kate Bennett, Caroline J Doré, Macey L. Murray, (unknown), Lewis Haddow, Charles Lacey, Frank Sandmann, Mark Jit, Kate Soldan, (unknown), (unknown), Mayura Nathan, Andrew Copas	21
7	2019 IUSTI‐Europe guideline for the management of anogenital warts 2020 ·Journal of the European Academy of Dermatology and Venereology ·Richard Gilson, Diarmuid Nugent, Ricardo Niklas Werner, J. M. Ballesteros, Jonathan Ross	63
8	Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study 2019 ·Health Technology Assessment ·Carina King, Carrie Llewellyn, Maryam Shahmanesh, Charles Abraham, Julia Bailey, Fiona Burns, (unknown), Andrew Copas, Alison Howarth, Gwenda Hughes, Catherine H Mercer, Alec Miners, Alex Pollard, Daniel Richardson, Alison Rodger, (unknown), Richard Gilson	11
9	Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study 2019 ·International Journal of Drug Policy ·Janey Sewell, Valentina Cambiano, Andrew Speakman, Fiona Lampe, Andrew Phillips, David Stuart, Richard Gilson, David Asboe, Nneka Nwokolo, Amanda Clarke, Alison Rodger	77
10	PRIME (Positive Transitions Through the Menopause) Study: a protocol for a mixed-methods study investigating the impact of the menopause on the health and well-being of women living with HIV in England 2019 ·BMJ Open ·Shema Tariq, Fiona Burns, Richard Gilson, Caroline Sabin	16
11	Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial) 2018 ·BMC Medical Research Methodology ·Macey L. Murray, (unknown), Caroline J Doré, Andrew Copas, Lewis Haddow, Charles Lacey, Mark Jit, Kate Soldan, Kate Bennett, (unknown), Mayura Nathan, Richard Gilson	21
12	A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK 2018 ·BMJ Open ·Matt Lechner, (unknown), (unknown), Oliver Jones, James Howard, Liam Masterson, Tim R. Fenton, Wendell G. Yarbrough, Jo Waller, Richard Gilson	19
13	'You're suffering all these things and you keep going backwards and forwards': experiences of the menopause among women living with HIV in the United Kingdom 2017 ·UCL Discovery (University College London) ·(unknown), (unknown), Fiona Burns, Richard Gilson, (unknown), Shema Tariq, (unknown)	4
14	Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics 2017 ·International Journal of Drug Policy ·Janey Sewell, Ada Miltz, Fiona Lampe, Valentina Cambiano, Andrew Speakman, Andrew Phillips, David Stuart, Richard Gilson, David Asboe, Nneka Nwokolo, Amanda Clarke, Simon Collins, Graham Hart, Jonathan Elford, Alison Rodger	166
15	A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England 2017 ·BMJ Open ·Annabelle Gourlay, Julie Fox, Mitzy Gafos, Sarah Fidler, Nneka Nwokolo, Amanda Clarke, Richard Gilson, Chloe Orkin, Simon Collins, Kholoud Porter, Graham Hart	14
16	Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study) 2016 ·JMIR Research Protocols ·Janey Sewell, Andrew Speakman, Andrew Phillips, Valentina Cambiano, Fiona Lampe, Richard Gilson, David Asboe, Nneka Nwokolo, Amanda Clarke, (unknown), Simon Collins, Alison Rodger	7
17	'Positive Voices' a survey of the behaviour, experiences, and healthcare needs of people living with HIV: A pilot study methods and respondent characteristics 2015 ·UCL Discovery (University College London) ·Meaghan Kall, Anthony Nardone, Valérie Delpech, Richard Gilson, Maryam Shahmanesh	0
18	Hepatitis C viral load in semen of HIV-positive men during acute and chronic hepatitis C infection 2010 ·UCL Discovery (University College London) ·Jeffrey D. Turner, Emma Aarons, (unknown), H. James Price, Bridget Ferns, Andrew Copas, Richard Gilson	2
19	Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? United Kingdom Collaborative HIV Cohort Study Group 2009 ·UCL Discovery (University College London) ·(unknown), Clifford Leen, Jonathan Ainsworth, J. Anderson, (unknown), Philippa Easterbrook, Michael T. Fisher, Brian Gazzard, Richard Gilson, Mark Gompels, Tetiana Hill, (unknown), Chloe Orkin, AN Phillips, Kholoud Porter, Frank Post, John Walsh, Caroline Sabin, (unknown)	7
20	Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters 2004 ·AIDS ·Krishnan Bhaskaran, Deenan Pillay, A. Sarah Walker, Martin Fisher, David Hawkins, Richard Gilson, Ken McLean, Kholoud Porter	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact